Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

Background: Mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) colorectal tumors constitute 5% of metastatic colorectal cancer(mCRC). Immunotherapy is a new standard, but it is difficult to provide for all patients. 5-Flurouracil-based treatment with anti-EGFRs (cetuximab and p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	İlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk, Taha Koray Sahin, Murat Kiracı, Ahmet Melih Arslan, Eda Karapelit, Bahar Beliz Karaoğlan, Nargiz Majidova, Elif Şahin, Sabin Göktaş, Abdullah Sakin, Ali Oğul, Emine Türkmen, Kadriye Başkurt, Zeynep Yüksel Yaşar, Yakup Ergün, Esma Türkmen Bekmez, Şafak Yıldırım Dişli, Sinem Akbaş, Sema Türker, Ömer Dizdar, Öznur Bal, Tuğba Yavuzşen, Melek Karakurt, Arzu Hatime Yaşar, Tuğba Başoğlu, Faysal Dane, Şuayip Yalçın, Öztürk Ateş
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-11-01
coleção:	Current Oncology
Assuntos:	dMMR colorectal cancer MSI-H colorectal cancer anti-EGFR anti-VEGF
Acesso em linha:	https://www.mdpi.com/1718-7729/32/11/639
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!